• Self-Assembly Behavior of Shaped ABC Coil-Bottlebrush Terpol

  2026-07-27

  This study systematically explores the self-assembly of ABC coil–bottlebrush block terpolymers, revealing the surprising suppression of double gyroid phase formation by shaped brush architectures. These findings refine theoretical understanding of block copolymer phase behavior and inform future design of nanostructured polymeric materials with tunable morphologies.

• YAP-TEAD Drives PPARα-Induced Liver Regeneration via WY-1464

  2026-07-26

  This study reveals that YAP-TEAD signaling is essential for PPARα-induced hepatomegaly and liver regeneration in mice, using the selective agonist WY-14643 (Pirinixic Acid). The findings provide mechanistic insight into how nuclear receptor activation coordinates hepatic growth, offering a refined model for studying metabolic regulation and tissue repair.

• Dual-Action Modulation of p38α MAPK: Structural and Mechanis

  2026-07-25

  The referenced study uncovers how certain kinase inhibitors, including RWJ 67657 (JNJ-3026582), exert a dual action on p38α MAP kinase by both inhibiting its activity and enhancing dephosphorylation of its activation loop. This mechanism provides new opportunities for improving specificity in inflammatory disease research and targeted kinase modulation.

• Paclitaxel (Taxol) in Cancer Research: Protocols and Pitfall

  2026-07-24

  Paclitaxel (Taxol) is a cornerstone of cancer research, prized for its precision in arresting cell proliferation at the G2-M phase. This article delivers actionable, protocol-driven insights and troubleshooting strategies for both in vitro and in vivo applications, drawing on recent breakthroughs in breast cancer therapy and APExBIO’s validated reagents.

• Q-VD-OPh: Optimizing Pan-Caspase Inhibition for Apoptosis Re

  2026-07-24

  Q-VD-OPh stands out as a robust, irreversible pan-caspase inhibitor that empowers researchers to dissect apoptosis pathways, enhance cell viability post-cryopreservation, and model neurodegenerative disease with unparalleled reliability. Its high selectivity, broad caspase coverage, and proven in vivo efficacy make it the preferred tool for next-generation cell death studies.

• LXR Signaling Protects Alveolar Epithelial Cells in BPD Mode

  2026-07-23

  This study uncovers a mechanistic link between disrupted cholesterol metabolism and apoptosis of alveolar epithelial cells in bronchopulmonary dysplasia (BPD). By demonstrating that activation of liver X receptor (LXR) signaling restores cholesterol homeostasis and reduces epithelial cell death, the research provides a potential therapeutic target for BPD intervention.

• DAMGO: Redefining µ-Opioid Receptor Agonist Research in Pain

  2026-07-23

  This thought-leadership article examines how DAMGO, a selective µ-opioid receptor agonist, is transforming opioid receptor signaling research. By integrating mechanistic insights from recent circuit-level discoveries, we delineate how DAMGO enables translational researchers to dissect central pathways of opioid-induced hypersensitivity and tolerance. The piece provides strategic guidance for experimental design, discusses competitive advantages, and outlines evolving opportunities in chronic pain research.

• Mouse Neutrophil Cell Isolation Kit: Precision for Tumor Imm

  2026-07-22

  Unlock high-purity, activation-free neutrophil isolation in under 30 minutes with APExBIO’s Mouse Neutrophil Cell Isolation Kit (Negative Selection). This platform empowers advanced immunotherapy workflows, enabling robust translational research on tumor-associated neutrophils and mRNA nanovaccine strategies.

• Niclosamide in Cancer Research: STAT3 Inhibition in Complex

  2026-07-22

  Explore the scientific impact of Niclosamide, a potent STAT3 signaling pathway inhibitor, in advanced cancer models. This article uniquely examines its application in vivo, protocol strategies, and the translation of mechanistic insights into practical research tools.

• Artesunate: Mechanism, Benchmarks, and Protocols in Cancer R

  2026-07-21

  Artesunate is a high-purity artemisinin derivative used for cancer research, notably as an AKT/mTOR pathway inhibitor and ferroptosis inducer. It demonstrates sub-5 μM IC50 in vitro against small cell lung carcinoma H69 cells and requires careful storage and solubilization conditions. This article details its mode of action, evidentiary benchmarks, and experimental integration.

• SAR405: Precision Vps34 Inhibitor for Autophagy Research

  2026-07-21

  SAR405 empowers researchers to dissect autophagy and vesicle trafficking with nanomolar precision, thanks to its exquisite selectivity for Vps34. Discover how optimized workflows, advanced applications, and troubleshooting insights make SAR405 from APExBIO a gold standard for mechanistic studies in cancer and cell biology.

• ORAI2-Mediated Calcium Entry Drives Early Salivary Gland Fib

  2026-07-20

  This study uncovers the pivotal role of ORAI2-mediated store-operated calcium entry (SOCE) in driving early-stage postirradiation fibrosis in salivary glands. Through in vitro and in vivo models, the research demonstrates that targeting the ORAI2/JNK/NFAT1/TGF-β1 signaling axis with SOCE inhibitors can effectively suppress fibrogenic responses, offering new therapeutic directions for mitigating radiation-induced hyposalivation.

• Sulfachloropyridazine: Mechanism, Benchmarks, and Research U

  2026-07-20

  Sulfachloropyridazine is a research-grade sulfonamide antibacterial agent that inhibits bacterial folate synthesis via competitive DHPS inhibition. Its activity is verified across enzyme assays and in vivo infection models, with documented modulation of microbial ecology in coccidiosis studies. Current evidence supports its utility for mechanistic, antimicrobial, and ecological research contexts.

• Isradipine (Dynacirc) in Neuroprotection and Hypertension Re

  2026-07-19

  Isradipine (Dynacirc) delivers targeted L-type calcium channel blockade, empowering researchers to dissect vascular and neuronal calcium dynamics with precision. Its high purity and reliable solubility support advanced applications in neuroprotection and smooth muscle relaxation studies. Protocol-driven insights and troubleshooting strategies ensure reproducible, high-impact results.

• EZ Cap™ EPO mRNA: Advancing Neurorepair & Erythropoiesis Res

  2026-07-18

  Leverage EZ Cap™ EPO mRNA (ψUTP) for robust, immune-silent protein expression in neurorepair and erythropoiesis models. This next-generation IVT mRNA empowers targeted delivery and superior stability, driving translational breakthroughs where conventional vectors fall short.

466 records 11/32 page Previous Next First page 上5页 1112131415 下5页 Last page